Tag: Business

the-main-target-and-focus-the-article-focuses-on-key-figures-attending-the-jp-morgan-healthcare-conference-on-day-2new-title-highlights-from-jp-morgan-healthcare-conference-day-2

The Main Target and Focus: The article focuses on key figures attending the J.P....

Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...
unveiling-jpm-day-1-a-comprehensive-overview-for-nvestors

Unveiling JPM Day 1: A Comprehensive Overview for Investors

Unveiling JPM Day 1: A Comprehensive Overview for InvestorsWelcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech world is abuzz with groundbreaking news, insightful analysis, and juicy...
brian-thompson-the-rise-and-fall-of-unitedhealthcares-ceo

Brian Thompson: The Rise and Fall of UnitedHealthcare’s CEO

MAPLE GROVE, Minn. - On a fateful day in New York City, the world lost Brian Thompson, the esteemed CEO of UnitedHealthcare. Thompson's journey from a small town in Iowa to the pinnacle of...
news-01122024-072554

Medicare Obesity Drug Coverage and 340B Analysis: Pharmalittle Updates

Good day, everyone! We hope you are all well despite the rainy weather. Remember, each day is a gift waiting to be unwrapped. As we take a short break for the upcoming holiday, let's...
news-29112024-062000

AI Drug Development Company Recursion Cuts Jobs Post Exscientia Merger

Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay off employees following a merger with Exscientia. This move comes...
news-27112024-175935

Biotech News Roundup: Stay Updated on the Latest Developments in the Industry

Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...
news-22112024-082138

Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know

Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...
news-22112024-082107

FAQs: Understanding IGAs in Animals

Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA sequence changes like insertions, substitutions, or deletions, among others. Common...
news-21112024-183110

Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment

Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not only the gene therapy startup itself but also its drug...
news-21112024-122547

Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker

Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia. The drug, ziftomenib, is currently in a late-stage clinical trial...
news-20112024-122223

Apellis Triumphs while Astellas Faces Defeat

Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless has launched a new biotech company called Jupiter. Here's what you...
news-20112024-062138

RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability

Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....

BREAKING NEWS

Top News